Sale!

CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the CEP57 gene responsible for Mosaic Variegated Aneuploidy Syndrome Type 2. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect genetic abnormalities that cause developmental delays, microcephaly, growth retardation, and increased cancer risk. The test is particularly valuable for pediatric patients presenting with dysmorphic features and chromosomal instability. Priced at $500 USD, this advanced genetic analysis provides crucial information for accurate diagnosis, family planning, and personalized medical management strategies. Results are available within 3-4 weeks from blood or DNA samples.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 NGS Genetic DNA Test

Comprehensive Genetic Analysis for Rare Pediatric Conditions

The CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for rare genetic disorders. This advanced testing methodology provides precise detection of mutations in the CEP57 gene, which plays a critical role in chromosomal stability and cell division. Understanding this genetic condition is essential for early intervention and personalized treatment approaches.

What Does This Test Measure?

Our comprehensive NGS-based genetic test specifically targets the CEP57 gene to identify pathogenic variants associated with Mosaic Variegated Aneuploidy Syndrome Type 2. The test examines:

  • Complete sequencing of the CEP57 gene coding regions
  • Detection of point mutations, insertions, and deletions
  • Identification of mosaic chromosomal abnormalities
  • Assessment of genetic variants affecting centrosome function
  • Analysis of mutations impacting mitotic spindle formation

Who Should Consider This Test?

This genetic test is particularly recommended for individuals presenting with the following symptoms or clinical features:

  • Infants and children with developmental delays and intellectual disability
  • Patients exhibiting microcephaly (small head circumference)
  • Individuals with growth retardation and failure to thrive
  • Children showing dysmorphic facial features
  • Patients with increased cancer predisposition, particularly Wilms tumor
  • Individuals with family history of chromosomal instability disorders
  • Patients with unexplained congenital anomalies

Clinical Benefits of Genetic Testing

Undergoing the CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 test provides numerous advantages for patients and families:

  • Accurate Diagnosis: Confirms or rules out MVA syndrome type 2 with high precision
  • Early Intervention: Enables timely medical management and therapeutic interventions
  • Cancer Surveillance: Identifies increased risk for specific malignancies, allowing for proactive monitoring
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Personalized Care: Guides development of tailored treatment plans based on genetic findings
  • Prognostic Information: Helps predict disease progression and potential complications

Understanding Your Test Results

Our comprehensive genetic counseling team will help you interpret your results with clarity and compassion:

  • Positive Result: Indicates the presence of pathogenic CEP57 gene mutations, confirming Mosaic Variegated Aneuploidy Syndrome Type 2 diagnosis
  • Negative Result: Suggests absence of detectable CEP57 mutations, though other genetic conditions may need consideration
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation
  • Mosaic Findings: Detects genetic abnormalities present in only some cells, requiring specialized interpretation

Test Information and Pricing

Test Component Details
Test Name CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure optimal testing outcomes, we recommend:

  • Comprehensive clinical history of the patient
  • Genetic counseling session to create detailed family pedigree
  • Documentation of affected family members with similar symptoms
  • Review of previous genetic testing and medical evaluations

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and medical professionals ensures accessible, high-quality care regardless of your location.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about genetic conditions impact your family’s health and future. Our expert team is ready to guide you through the testing process with compassion and clinical excellence. Schedule your genetic counseling session and testing today to gain valuable insights into your genetic health.

Call or WhatsApp us now at +1(267) 388-9828 to book your CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 NGS Genetic DNA Test and take control of your genetic health journey.